#4 of pharma imports · Antibiotics
Rifampicin & salts: imports into India
Tariff lines 29419011, 29419019 · CAS 13292-46-1
Imports 2025-26
698 t
+14.8% vs 2024-25
Import bill (CIF, before duty)
₹913 cr
Volume growth, 2020-21 to 2025-26
-1.2% a year
Steady
Net imports 2025-26
576 t
Exports 122 t
Import volume by financial year
SteadyShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 742 t | ₹863 cr |
| 2021-22 | 805 t | ₹1,003 cr |
| 2022-23 | 560 t | ₹792 cr |
| 2023-24 | 440 t | ₹685 cr |
| 2024-25 | 608 t | ₹850 cr |
| 2025-26 | 698 t | ₹913 cr |
Where it comes from (2025-26)
Share of the import bill
- China80.4%
- Mexico13.3%
- Austria1.1%
What's changing
- Macleods Pharmaceuticals is the approved applicant for rifampicin under the bulk-drug PLI scheme.Department of Pharmaceuticals, 6 Nov 2023
- In March 2025 officials said the rifampicin project was at an advanced stage and expected to be commissioned later that year.The Health Master (ANI), 17 Mar 2025
Reported facts with their source. Not a forecast.
Buy or supply rifampicin & salts in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.